Almost all patients (38/39) had type 1 narcolepsy, confirmed by cerebrospinal hypocretin-1 assay in 34 cases; 27% (10) were obese and 54% (21) had at least one other disease. Here, HCRT is linked to narcolepsy-cataplexy syndrome.